13 oct 2020
CPhI Worldwide 2020
Singapore Biotech

Singapore Biotech

Exhibitor at CPhI Worldwide 2020 stand 5B27

About us

Singapore Biotech is a trusted Biologic company that changes lives by making advanced biologics more accessible and more affordable.
The EU-GMP certified manufacturing facilities enable us to deliver world-class quality biosimilars to patients, across the globe.
Utilizing latest manufacturing technologies is our competitive edge to support our international partners to increase uptake of biosimilars in different regions.

Business Model and Partnering Structures at Singapore Biotech:

·         Out licensing
·         Supply and Distribution (API and Finished Product)
·         Technology Transfer
·         Co-Development
·         Contract Manufacturing

Our Target Therapeutic Areas:

·         Neurology (Interferon beta-1a)
·         Oncology & Hematology (Erythropoietin beta, Pegylated filgrastim, Rituximab, Trastuzumab, Bevacizumab and rFactor VII)
·         Gynecology & Endocrinology (Follitropin alfa and Somatropin)
·         Rheumatology (Teriparatide, Adalimumab and Etanercept)

Specs about this supplier

Affiliated categories: Antibodies |Biomanufacturing |Biopharmaceuticals (general category) More

Products featured at CPhI Worldwide 2020

Singapore Biotech

Event information

CPhI Worldwide 2020

13 - 15 October 2020 Milan, Italy Visit us at stand 5B27